Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_32_библиотеки_им_акад_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
22 Мб
Скачать
162 Urinary Incontinence
https://t.me/medicina_free
stimulation (TENS) is thought to improve blad­der control by modifying interneuronal interac­tion at spinal cord level. Success rates of up to 60% have been reported but the duration of improve­ment is variable.
Posterior Tibial Nerve Neurostimulation
In this technique a ne needle is inserted into the vicinity of the tibial nerve in the lower leg and an electrode pad is placed over the heel. Electrical impulses are transmitted via the tib­ial nerve to the spinal cord and sacral plexus. Treatment typically consists of weekly sessions of 30 minutes duration over 12 weeks. Posterior tibial nerve neurostimulation has been approved by the UK National Institute for Clinical Excellence (NICE) for the treatment of refrac­tory detrusor overactivity. Although mainly used in adults it has also been used in children and young people.
Sacral Nerve Stimulation
is is an invasive intervention which entails sur­gical implantation of a stimulator in the region of the sacral nerves. It has been used more exten­sively in adults but experience in children is very limited.
Intravesical Botulinum A Toxin Injection
is approach is being increasingly used in chil­dren with severe bladder overactivit y which has not responded to other forms of treatment. Cystoscopy is performed under general anaesthesia and small doses of Botulinum A toxin are injected into the bladder wall muscle at multiple sites.
Up to 15% of children experience impaired bladder emptying or urinary retention follow­ing intravesical Botox injection and for this reason the possible requirement for clean inter­mittent catheterisation (CIC) must be explained (or even taught) prior to the procedure. e duration of response to intravesical Botox is variable but may be of the order of 6–9 months. One or more further injections may be required.
Nevertheless, intravesical Botox injections may be valuable in conferring a period of symp­tomatic relief while other measures are being introduced.
OTHER FORMS OF FUNCTIONAL URINARY INCONTINENCE
Urge Syndrome/Motor Urgency
Daytime wetting is accompanied by symptoms of urgency in more than 80% of children. e child only becomes aware of the sensation of needing to void shortly before the act of voiding super­venes. Indeed, many children claim that they do not realise that they are voiding at all.
Urgency tends to occur when the bladder is full rather than during lling. e cause is unknown but it is likely to be a manifestation of delayed maturation of normal bladder control. Children may attempt to prevent impending leakage of urine by contracting their urethral sphincter and pelvic oor muscles. In some children this may be reinforced by additional manoeuvres – notably crouching with the heel pressed into the perineum (Vincent’s curtsy sign).
Dysfunctional Voiding
is is characterised by a urinary ow which is of varying intensity or interrupted (“staccato”) voiding. Urodynamic studies demonstrate detrusor-sphincter dyssynergia with either incomplete relaxation of the sphincter or alter­nating phases of contraction and relaxation. Voiding is oen incomplete. e most likely explanation is that children who have learned to use voluntary contraction of the urethral sphincter to suppress leakage due to detru­sor instability then go on to adopt a pattern of behaviour which prevents them from relaxing the sphincter during deliberate voiding. e condition is virtually conned to girls and is accompanied by recurrent urinary infections in more than 90% of cases. Vesicoureteric reux (with or without renal scarring) is present in
Other forms of functional urinary incontinence / Diurnal Urinary Frequency 163
https://t.me/medicina_free
around 30% of cases. is is mostly secondary reux caused by sustained exposure to elevated intravesical pressures generated by a com­bination of detrusor overactivity and detru­sor-sphincter dyssynergia. e treatment of dysfunctional voiding centres on “re-educating the voiding mechanism” – initially with a regu­lar voiding regimen and other simple measures. For those suering from more severe forms of dysfunctional voiding a range of techniques is now available which can be grouped under the heading “Urotherapy” or “Cognitive Bladder Training.” e key elements involve biofeedback (using uroowmetry and dedicated computer programmes) to train the child to relax their sphincter mechanism and pelvic oor during voiding in response to visual and sensory sig­nals. High success rates have been reported but these techniques are time consuming, demand­ing and require the input of a fully trained uro­therapist and appropriate equipment.
Non-Neuropathic Neuropathic Bladder/Hinman’s Syndrome
is is a rare disorder in which the bladder behaves like a “neuropathic” bladder despite the absence of identiable neurological cause. e radiological features resemble those of genu­ine neuropathic bladder – including trabecula­tion, sacculation and elongation of the bladder (“r-tree” bladder). Upper tract dilatation and other secondary changes in the upper renal tracts are also present in the majority of cases.
In the classic form (Hinman’s syndrome), there is almost invariably a background of domestic turmoil or a history of severe physical or psychological upset occurring at, or shortly aer, the time of toilet training. It is thought that some children, who are unusually fearful of wet­ting themselves, grossly overuse their external urethral sphincter to counteract unstable detru­sor contractions in a desperate attempt to stay dry. is leads to elevated intravesical pressure and reduced compliance, with secondary upper tract complications.
e condition typically presents at around 5–8 years of age with unusually severe urinary incontinence which is compounded in most
cases by UTIs and marked disturbance of bowel habit. However, this condition may also develop at a later age and, as in younger children, may be accompanied by symptoms of renal insuf­ciency in severe or longstanding cases. e natural history is variable but, if untreated, the condition carries a very real threat of severe upper tract damage and renal insuciency. Expectant management is not a safe option. e treatment options are the same as those for the management of true neuropathic bladder (see
Chapter 13). Very rarely a child will present with
the features of a non-neuropathic neuropathic bladder despite the lack of any history of psycho­logical disturbance. Bowel function is usually normal. e management is the same as for true neuropathic bladder
Sensory Urgency
is poorly understood condition is largely conned to girls. Despite clinical features which are strongly suggestive of detrusor over­activity, urodynamic evaluation reveals a stable bladder. e symptoms of urgency are purely sensory in origin. Sensory urgency in adults is a feature of interstitial cystitis but it is very doubtful whether this condition occurs in chil­dren. e use of intravesical oxybutynin has been described.
Diurnal Urinary Frequency
is condition aects mainly boys aged 4–7 years in whom it is characterised by the sudden onset of severe daytime urinary frequency. In some cases this may be as oen as every 10–15 minutes. Even when the sensory frequency is severe it is only rarely accompanied by wetting. e symptoms are conned to the day time and there is no corre­sponding nocturia. Urine culture is negative and ultrasound ndings are normal. e aetiology is unknown but is likely to involve a strong behav­ioural component. e symptoms do not respond to anticholinergics. e condition is always self­limiting – typically over a period of 3–12 weeks. However, a few children experience recurrent episodes over the next 1–2 years.
164 Urinary Incontinence
https://t.me/medicina_free
Deferred Voiding
is is common in both sexes and occurs most oen at around 4–6 years of age. e child sud­denly becomes aware of an urgent need to void (due to presumed unstable detrusor contraction) and experiences some degree of involuntary wet­ting if voiding is delayed. is usually occurs because the child is engrossed in other activities, for example playing outdoors, which take prece­dence over the social demands of continence. No treatment is required in this age group because the condition is self-limiting. Deferred voiding is less common in older children – in whom it may be a manifestation of broader behavioural distur­bance. Psychological input may be required in such cases.
Lazy Bladder
Aecting mainly girls in age range 8–10 years, this condition usually presents with daytime incontinence and/or UTI. However, because the bladder remains visibly and palpably distended aer voiding the condition may sometimes pres­ent with the incidental nding of a lower abdomi­nal swelling.
e upper renal tracts are always non dilated and the urodynamic picture is one of low­pressure retention with detrusor-sphincter dyssynergia and non-sustained detrusor contrac­tions. e condition is almost certainly behav­ioural in origin. It is usually self-limiting and oen resolves quite suddenly during the course of puberty. For children who are troubled by symptoms, cognitive bladder retraining has the best outcome. In severe cases CIC may be indicated – although this may not be tolerated. Anticholinergics should be avoided or used with caution.
Giggle Incontinence
normal. Giggle incontinence is a source of con­siderable embarrassment and distress in older children and teenagers – both at school and dur­ing social activities. Urodynamic examination may reveal some mild detrusor instability but the ndings are usually normal. Giggle inconti­nence is generally believed to be a neurological (rather than urological) phenomenon which is analogous to a form of cataplexy disorder medi­ated via higher neurological centres in which a sudden loss of muscle tone is triggered by emo­tion. ere is oen a family history. Whether it is a genuinely self-limiting condition is unclear because apparent improvement in puberty and early adult life may, in reality, represent no more than adaptation to avoid the precipitating circumstances.
Methylphenidate (Ritalin) is the most consis-
tently eective agent. However, it is a regulated drug and should be reserved for severely aected patients. Oxybutynin is helpful in some cases and Imipramine can also be considered.
Night Time Urinary Incontinence (Nocturnal Enuresis)
Nocturnal enuresis (bedwetting) is one of the commonest conditions of childhood. Around 10% of 7-year-old children wet the bed three or more times a week and a small minority experi­ence intractable nocturnal enuresis which per­sists into late adolescence and adulthood.
Urinary incontinence which only occurs at
night is termed “monosymptomatic” whereas noctur nal enuresis which is al so accompanied day­time wetting is termed “non-monosymptomatic” or “polysymptomatic”.
Nocturnal enuresis is classied as “primary” if the child has always wet the bed and “second- ary” if the child has previously been dry at night.
Butler and Holland postulated a “3 Systems Model” to account for the main causes of noctur­nal enuresis (Figure 12.6) i.e.
is distinctive form of incontinence occurs mainly in girls – in whom it typically presents at around 9–12 years. Urinary leakage only occurs with giggling or laughing but at no other time. Other aspects of voiding function are entirely
Low release of Arginine Vasopressin (AVP)
with overproduction of urine at night
Lack of arousal from sleep
Bladder overactivity and associated daytime
symptoms
Other forms of functional urinary incontinence / Secondary Monosymptomatic Nocturnal Enuresis 165
https://t.me/medicina_free
Figure 12.6 The 3 systems model of nocturnal enuresis.
e aim of management is to identify which of these factors is most likely to be responsible in the aected child and plan t heir treatment accordingly.
Primary Monosymptomatic Nocturnal Enuresis
is is twice as common in boys as girls. e clini­cal features are variable and whilst some children wet the bed every night others are less severely aected, with less severe leakage, fewer wet beds or alternating spells of wet and dry nights.
e aetiology is multifactorial and in any individual one or more of the following factors may apply:
A positive family history (in upwards of 75%
of cases).
Absence of a circadian rhythm of vasopressin
release. Levels of vasopressin normally
increase at night. However, vasopressin release is absent or reduced in up to 75% of children who wet the bed (and in an even higher proportion of those with a positive family history). is leads to a nocturnal urinary output which exceeds the functional bladder capacity.
Sleep arousal diculty. Nocturnal enuresis
does not, as is commonly supposed, result
from abnormally deep sleep, as bed wet­ting occurs at all stages of the sleep cycle. However, many aected children lack the arousal from sleep which would normally occur when the bladder lls to the point where it approaches its functional bladder capacity. e child usually sleeps through the episode of incontinence, being unaware that they have wet the bed.
Although nocturnal enuresis is sometimes a man­ifestation of emotional problems or behavioural disorders, the great majority of children with primary monosymptomatic nocturnal enuresis are normally adjusted. Apart from a urine dip­stick test (to exclude glycosuria and diabetes) investigations are rarely indicated. e prognosis is excellent, with spontaneous resolution by the time of physical maturity occurring in 97–99% of aected individuals. e probability of cessation in any 1 year is approximately 1 in 6.
Secondary Monosymptomatic Nocturnal Enuresis
In the majority of cases the onset can usually be linked to some physical or emotional upset.
However, it is important to exclude the possibil-
ity of an underly ing organic condition – par ticularly
166 Urinary Incontinence
https://t.me/medicina_free
one associated with polyuria such as diabetes mellitus or diabetes insipidus. However, such causes are rare.
Treatment of Monosymptomatic Nocturnal Enuresis
is should not usually be considered until the age of 5 years. e choice of treatment is partly determined by the clinical features. But regard­less what treatment is chosen its success will be heavily dependent on the motivation of the child and the family. Although treatment provides a way of managing rather than curing the condi­tion, eective symptomatic relief may help to expedite the resolution of the underlying noctur­nal enuresis sooner than might otherwise have been the case.
Parents should be encouraged to adopt a posi­tive attitude to treating the bedwetting. Scolding and punishment are to be avoided at all costs. e management of monosymtomatic nocturnal enuresis is generally undertaken in a community setting by primary care doctors, paediatricians and specialist continence nurses.
Simple Measures to Reduce Overnight Urine Production
e child should not drink aer a set time in the evening (e.g. 6 pm) and should try to maintain a steady intake of uid throughout the day rather than drinking more in the aernoon or early eve­ning. It is also important that the child empties their bladder before going to bed.
e use of star charts, combined with rewards, can be particularly helpful in younger children.
Use of a Vasopressin Analogue Such as Desmopressin
is mimics the circadian rhythm by decreas­ing the obligatory production of urine by the kidneys overnight. e success rate is up to 70% but the relapse rates aer cessation of treatment are relatively high (30–50%). is treatment is more likely to be eective in children with a family history of nocturnal enuresis and those who wet the bed shortly aer going to sleep. e
success rate is lower in children who also suf­fer from day time wetting. Desmopressin nasal spray products are no longer available because of the small risk of serious adverse reactions which included hyponatraemia, seizures and water intoxication.
Oral formulations have a more favourable
risk-benet prole. Currently, these are avail­able as Desmotabs (200–400 mg at night) or Desmomelt (120–240 mg at night) and are usu­ally taken 1hour prior to bedtime.
Enuresis Alarm
Children with a deep sleeping pattern are the best candidates for treatment with an enuretic alarm. ese alarms are intended to sensitise the child to the feeling of a full bladder and raising their level of awareness whilst asleep. Aer a while the child acquires the ability to respond appropri­ately by waking before leakage of urine occurs. e equipment typically consists of an auditory or vibratory alarm connected to a pad placed on the mattress (Figure 12.7). e alarm is acti­vated when the rst drop of urine leaks onto the pad. Enuresis alarms are more eective in children aged 7 years and upwards – in whom success rates are typically in the range 60–75%. Subsequent relapse rate are much lower than those aer treatment with medication. Alarms are less successful in children who are not moti­vated to become dry and those who also suer from daytime wetting.
Nocturnal hypoxia has been identied as a possible cause of nocturnal enuresis in some chil­dren with history of snoring and/or poor atten­tion during the day at school. e ndings of sleep studies have also been cited by proponents of this possible explanation. Although, tonsillec­tomy has been reported to cure nocturnal enure­sis in selected cases this has not been conrmed by a recent prospective controlled trial.
Non-Monosymptomatic or Polysymptomatic Nocturnal Enuresis
When nocturnal enuresis is accompanied by day symptoms such as urgency, frequency, stress incontinence and constipation, the rst priority
Other forms of functional urinary incontinence / Non-Monosymptomatic 167
https://t.me/medicina_free
KEY POINTS
e initial priority is to exclude organic causes of urinary incontinence – although these are rare.
Most organic (anatomical or neurologi­cal) causes of daytime wetting can be excluded on the basis of history, exami­nation and ultrasonography.
Day time wetting in children is most commonly due to detrusor instability. In the majority of children the natural history is one of spontaneous resolu­tion but this can usually be expedited by simple measures.
Primary monosymptomatic nocturnal enuresis seldom, if ever, has an under­lying organic basis.
Figure 12.7 (a) Enuresis alarm. The pad is
placed under the bed sheet, with bedside battery powered buzzer. (b) Compact enuresis alarm suitable for the treatment of nocturnal enuresis or ambulatory treatment of diurnal enuresis. The buzzer device is pinned to the pyjamas (or clothes when used in the day time) and the sensor worn between two pairs of underclothes.
should be to investigate the possible cause(s) of the daytime symptoms. In practice the nocturnal enuresis is unlikely to respond to measures such as an enuresis alarm until the day time wetting has been eectively treated. When used selectively (principally in children who are also troubled by daytime urgency and frequency) anticholinergic agents such as Oxybutynin are eective in up to two-thirds of cases. A combination of treatments may be required in some children – for example, the use of Desmopressin and an enuresis alarm. Imipramine, a tricyclic antidepressant, is no longer recommended as rst-line treatment and should never be prescribed in conjunction with Desmopressin.
FURTHER READING
1. Tryggve Nevéus, von Gontard Alexander,
Hoebeke Piet, Hjälmås Kelm, Bauer Stuart, Bower Wendy, Jørgensen Troels Munch, Rittig Søren, Walle Johan Vande, Yeung Chung-Kwong, Djurhuus Jens Christian. The standardization of ter­minology of lower urinary tract func­tion in children and adolescents: report from the Standardisation Committee of the International Children’s Continence Society. J Urol. 2006;176:314–324.
2. Butler R, Holland P. The Three Systems: a
conceptual way of understanding noc­turnal enuresis. Scan J Urol Nephrol. 2000;34:270–277.
NICE Clinical guidelines https://www.nice.org.
uk/guidance/cg111 (Bedwetting)
https://www.nice.org.uk/guidance/ipg362/
chapter/1-Guidance (PTNS)
Websites:
www.i-c-c-s.org www.eric.org.uk
https://t.me/medicina_free
Neurogenic Bladder
https://t.me/medicina_free
KYLE O ROVE and CHRISTOPHER S COOPER
Topics covered
13
Etiology Pathophysiology Prenatal intervention Newborn evaluation and management Investigations Treatment and outcomes Catheterization
INTRODUCTION AND DEFINITION
Neurogenic bladder is a non-specic term that implies an abnormality of innervation causing bladder dysfunction. Injury to the nervous system may be congenital or acquired, peripheral or cen­tral, isolated or syndromic. As the primary func­tions of the bladder are to store and empty urine through coordinated activity of the detrusor mus­cle and urinary sphincter, dysfunction may result in urinary incontinence, elevated storage or void­ing pressures, or incomplete emptying. Children and young people with neurogenic bladder are at risk of progressive deterioration in bladder function leading to kidney damage. Appropriate surveillance and management are crucial to main­taining renal function, achieving continence, and improving quality of life for these patients.
Increasing bladder capacity and reducing
pressure Bladder outlet procedures Transition to adulthood Sexual function Neurogenic bowel
ETIOLOGY
Spina bida is the most common cause of con­genital neurogenic bladder. In the United States, approximately 1,500 children with spina bida are born each year and the worldwide reported incidence is 3.1 per 10,000 births. e incidence has been decreasing over the last two decades but varies considerably by country and ethnic­ity. Myelomeningocele is the most severe form of spina bida, accounting for 90% of cases, while the remaining 10% are comprised of lipomyelo­meningocele or meningocele. Other congeni­tal causes of neurogenic bladder include closed and occult forms of neural tube defects such as tethered spinal cord, intradural lipoma, and intraspinal cysts. See Table 13.1. e term “spina bida occulta” may also be applied to an iso­lated vertebral anomaly consisting of incomplete
169
170 Neurogenic Bladder
https://t.me/medicina_free
Table 13.1 Etiology of childhood neurogenic
bladder
Congenital Acquired
Myelomeningocele Spina cord injury Sacral agenesis Spinal cord infarction Tethered cord Spinal cord tumor Closed and occult
forms of neural tube defects
Anorectal malformations Neuroblastoma
Sacrococcygeal
teratoma
Transverse myelitis Cerebral palsy Idiopathic causes
formation of the posterior spinous process. is anomaly, which is oen an incidental nding, is found in up to 15% of the population. It is con­ned to the bony elements the vertebrae and is rarely accompanied by any underlying neuro­logical lesion.
e critical period of neurulation (closure of the neural tube from cephalad to caudad) occurs in the rst few weeks of pregnancy. Adequate levels of folic acid are important for normal closure of the neural tube and low maternal dietary intake of folate or dysregulated folate metabolic pathways have been implicated as a major risk factor for the development of neural tube defects. In the United States, it is recom­mended that women should commence folate supplements 2 months prior to conception and women of childbearing age should consume 400 mcg folic acid daily. Other risk factors impli­cated in the etiology of neural tube defects include maternal obesity, diabetes mellitus, and advanced maternal age.
Survival rates of children born with myelo­meningocele have improved dramatically since the 1950s when less than 20% survived beyond 24 months of age. e development of the ven­triculoperitoneal (VP) shunt for the control of hydrocephalus led to signicantly improved sur­vival and by the mid-1970s the survival rate had increased to over 50%. It is predicted that more than 90% of the infants currently being born with spina bida will survive, with the majority living
into adulthood. e introduction of clean inter­mittent catheterization (CIC) by Lapides in 1972 was an important advance in the management of neurogenic bladder. Subsequently, the widespread introduction of urodynamic investigations led to recognition of the need for proactive manage­ment if the leak point pressure exceeded 40 cm of water or other adverse parameters of neurogenic dysfunction were demonstrated on urodynamics.
Other causes of congenital neurogenic blad­der include partial and complete sacral agenesis (caudal regression syndrome) which may occur in isolation or conjunction with anorectal and cloacal malformations. Acquired neurogenic bladder may be due to spinal cord trauma, tumors, extensive pelvic surgery, spinal cord infarction, transverse myelitis, developmental syndromes and cerebral palsy. Finally, certain adverse features of neurogenic bladder may be present in the acquired condition of non­neurogenic neurogenic bladder (or Hinman’s sy ndrome).
PATHOPHYSIOLOGY
Vertebral anomalies in the lumbosacral region account for about 50% of cases with lumbar and thoracic lesions accounting for 28% and 20% of cases respectively. It should be noted, how­ever, that the level of the vertebral abnormality does not correlate closely with the level of the neurological decit or the outcome for bladder function.
e functions of the normal bladder are to store urine and to empty under voluntary con­trol. ese functions are organized at the level of the brainstem and spinal cord. e sympa­thetic innervation of the detrusor muscle and urethral smooth muscle is mediated through the hypogastric nerve bers emanating from the lumbar region. e parasympathetic innerva­tion of the detrusor muscle is mediated by pelvic nerve pathways transmitted via the sacral roots S2 - 4 and the striated sphincter is innervated by the pudendal nerves also originating from the sacrum. Upper motor neuron lesions lead to an overactive bladder with no voluntary sphincter
Newborn evaluation and management / Initial Management 171
https://t.me/medicina_free
control. Contractions of an overactive blad­der against the resistance created by a non­relaxing sphincter (termed detrusor/sphincter dyssynergia) typically lead to detrusor hyper­trophy and a thick-walled bladder. Lower motor neuron lesions are characterized by an acon­tractile, accid detrusor, small, smooth walled bladder, and denervation of the external sphinc­ter. However, most spina bida patients have a mixed neurologic picture with features of both upper and lower motor neuron lesions.
PRENATAL INTERVENTION
As a consequence of widespread prenatal detec­tion of myelomeningocele by ultrasonography, fetal surgical intervention for the repair of these lesions has become a clinical reality. One pro­spective, randomized trial found that fetal inter­vention reduced the requirement for VP shunts and was associated with improved lower limb function at 12 and 30 months age. However, it did not result in any improvement in urody­namic parameters or any signicant reduction in the requirement for CIC. More recent data have suggested, however, that prenatal repair may reduce the need for CIC between 6 and 10 years of age and may perhaps increase the potential for spontaneous voiding. e complications of fetal repair include preterm delivery and uterine dehiscence.
neurogenic bladder in newborn infants with spina bida. e timing of commencement of CIC is considered below. A baseline renal and bladder ultrasound scan is performed aer 24–48 hours and renal function is assessed with serum cre­atinine or cystatin c. Following discharge from hospital a voiding cystourethrogram (VCUG) or video urodynamic study is performed aer 3 months of age. Baseline urodynamic param­eters assessed by this study should include; lling pressures, compliance, presence of detrusor over­activity, sphincteric function, leak point pres­sures, presence of vesicoureteral reux (VUR), and conguration of the bladder neck (open or closed). e ultrasound appearances of the kid­neys and bladder are abnormal in up to 20% of infants with myelomeningocele.
Spina Bida Occulta (Occult Spinal Dysraphism)
ese abnormalities include lipomeningomyelo­cele, tethered cord, and sacral agenesis. External signs of the underlying abnormality (prominent sacral dimple, fatty subcutaneous mass, tu of hair, hemangioma, or skin tag) are present in more than 80% of cases. External evidence of sacral agenesis is less obvious but may be appar­ent as an asymmetric gluteal cle. e spine can be evaluated with ultrasound in the rst 2 to 3 months of life but thereaer spinal magnetic resonance imaging (MRI) scan is the “gold stan­dard” imaging modality.
NEWBORN EVALUATION AND MANAGEMENT
Cesarean section is recommended to minimize trauma to the exposed neurologic tissue. At the time of delivery, an open myelomeningocele is immediately apparent as an exposed plaque of neural tissue. Closure of the lesion within the rst 24 hours is recommended to minimize the risk of ascending infection (meningitis).
ere are currently no standard evidence-
based guidelines for urologic management of
Initial Management
CIC is commenced if the bladder is not emptying to completion. However, when adequate bladder emptying is conrmed by clinical observation and ultrasound two options can then be considered;
1. Immediate commencement of clean inter-
mittent catheterization and anticholinergic medication.
Proponents of the early commencement of CIC argue that this is a logical form of management because at least 80% to 90% of patients with myelomeningocele will have